REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,264.00
Bid: 12,280.00
Ask: 12,282.00
Change: 146.00 (1.20%)
Spread: 2.00 (0.016%)
Open: 12,244.00
High: 12,384.00
Low: 12,228.00
Prev. Close: 12,118.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tuesday broker round-up UPDATE

Tue, 07th Oct 2014 09:45

African Minerals: Canaccord Genuity lowers target price from 20p to 15p with a hold recommendation.Aggreko: Exane initiates with a target price of 1500p and an underperform rating.Amec: Liberum Capital cuts target price from 1035p to 908p staying with its sell recommendation.Antofagasta: Canaccord Genuity reduces target price from 835p to 790p maintaining a hold recommendation. Nomura cuts target price from 720p to 700p, while upgrading to neutral.Arrow Global: Numis raises target price from 287p to 326p upgrading to buy.AstraZeneca: Deutsche Bank raises target price from 4000p to 4100p and stays with its hold recommendation. Panmure Gordon raises target price from 4400p to 4700p upgrading from hold to buy.Avon Rubber: N+1 Singer ups target price from 720p to 750p and keeps its buy recommendation.BAE Systems: Cantor Fitzgerald downgrades to hold with a target price of 460p.BHP Billiton: Canaccord Genuity cuts target price from 2020p to 1950p and retains a hold recommendation.BTG: Deutsche Bank raises target price from 655p to 745p keeping a buy recommendation.Central Asia Metals: Canaccord Genuity ups target price from 190p to 210p keeping a buy recommendation.Cranswick: N+1 Singer reduces target price from 1291p to 1246p reiterating a hold recommendation.Dixons Carphone: UBS initiates with a target price of 415p and a buy recommendation.easyJet: JP Morgan reduces target price from 1909p to 1815p and keeps an overweight rating.GlaxoSmithKline: Deutsche Bank cuts target price from 1450p to 1420p staying with a hold recommendation.Gooch & Housego: Investec cuts target price from 740p to 720p downgrading to add.Hummingbird Reources: Northland lowers target price from 98p to 94.2p and reiterates a buy recommendation.Hunting: Liberum Capital cuts target price from 802p to 763p downgrading to sell.ITE Group: Westhouse Securities cuts target price from 216p to 193p, while upgrading from neutral to add.John Wood Group: Liberum Capital reduces target price from 736p to 610p downgrading to sell.Kazakhmys: Canaccord Genuity ups target price from 260p to 280p maintaining a hold recommendation.Management Consulting: Canaccord Genuity lowers target price from 28p to 22p downgrading from buy to a speculative buy recommendation. Peel Hunt lowers target price from 30p to 21p and downgrades from buy to hold.Metminco: Canaccord Genuity lowers target price from 10p to 70p and keeps its speculative buy recommendation.Next Fifteen Communications: Canaccord Genuity shifts target price from 145p to 151p retaining a buy recommendation. Investec sOrsu Metals: Canaccord Genuity lowers target price from 4p to 3p and stays with its speculative buy recommendation.Petroceltic: Westhouse Securities downgrades to neutral with a target price of 240p.Petrofac: Liberum Capital reduces target price from 1223p to 1112p and keeps a hold recommendation.Pure Wafer: WH Ireland cuts target price from 115p to 96p, while leaving its buy recommendation unchanged.Rio Tinto: Canaccord Genuity reduces target price from 4165p to 4080p staying with its buy recommendation.Robert Walters: Oriel upgrades from add to buy.Sinclair IS Pharma: N+1 Singer lowers target price from 40p to 36p maintaining a buy recommendation.Spirent: Investec cuts target price from 105p to 80p, while its hold recommendation is kept.
More News
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.